OpenURL Connection Search

Select item for more details and to access through your institution.

Health-related quality of life in patients with non-alcoholic fatty liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2007, v. 26, n. 6, p. 815, doi. 10.1111/j.1365-2036.2007.03426.x
By:
- DAN, A. A.;
- KALLMAN, J. B.;
- WHEELER, A.;
- YOUNOSZAI, Z.;
- COLLANTES, R.;
- BONDINI, S.;
- GERBER, L.;
- YOUNOSSI, Z. M.
Publication type:
Article
Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan.
Published in:
Journal of Viral Hepatitis, 2018, v. 25, n. 8, p. 945, doi. 10.1111/jvh.12886
By:
- Younossi, Z. M.;
- Tanaka, A.;
- Eguchi, Y.;
- Henry, L.;
- Beckerman, R.;
- Mizokami, M.
Publication type:
Article
Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin.
Published in:
Journal of Viral Hepatitis, 2018, v. 25, n. 4, p. 354, doi. 10.1111/jvh.12830
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Schwarz, K. B.;
- Wirth, S.;
- Rosenthal, P.;
- Gonzalez‐Peralta, R.;
- Murray, K.;
- Henry, L.;
- Hunt, S.
Publication type:
Article
Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia.
Published in:
Journal of Viral Hepatitis, 2018, v. 25, n. 3, p. 228, doi. 10.1111/jvh.12808
By:
- Younossi, Z. M.;
- Chan, H. L. Y.;
- Dan, Y. Y.;
- Lee, M. H.;
- Lim, Y. S.;
- Kruger, E.;
- Tan, S. C.
Publication type:
Article
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 22, doi. 10.1111/jvh.12611
By:
- Tapper, E. B.;
- Bacon, B. R.;
- Curry, M. P.;
- Dieterich, D. T.;
- Flamm, S. L.;
- Guest, L. E.;
- Kowdley, K. V.;
- Lee, Y.;
- Tsai, N. C.;
- Younossi, Z. M.;
- Afdhal, N. H.
Publication type:
Article
Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus.
Published in:
Journal of Viral Hepatitis, 2016, v. 23, n. 11, p. 857, doi. 10.1111/jvh.12554
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Sulkowski, M.;
- Naggie, S.;
- Henry, L.;
- Hunt, S.
Publication type:
Article
Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus.
Published in:
Journal of Viral Hepatitis, 2016, v. 23, n. 8, p. 623, doi. 10.1111/jvh.12528
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Henry, L.;
- Younossi, I.;
- Weinstein, A.;
- Nader, F.;
- Hunt, S.
Publication type:
Article
Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.
Published in:
Journal of Viral Hepatitis, 2016, v. 23, n. 6, p. 447, doi. 10.1111/jvh.12506
By:
- Younossi, Z. M.;
- Bacon, B. R.;
- Dieterich, D. T.;
- Flamm, S. L.;
- Kowdley, K.;
- Milligan, S.;
- Tsai, N.;
- Nezam, A.
Publication type:
Article
The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
Published in:
Journal of Viral Hepatitis, 2016, v. 23, n. 1, p. 53, doi. 10.1111/jvh.12449
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Saab, S.;
- Ahmed, A.;
- Lam, B.;
- Srishord, M.;
- Venkatesan, C.;
- Wai, H.;
- Henry, L.
Publication type:
Article
Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 680, doi. 10.1111/apt.14484
By:
- Fukui, N.;
- Golabi, P.;
- Otgonsuren, M.;
- de Avila, L.;
- Bush, H.;
- Younossi, Z. M.
Publication type:
Article
Editorial: direct‐acting antivirals significantly improve quality of life in patients with hepatitis C virus infection—Author's reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 4, p. 537, doi. 10.1111/apt.14481
By:
- Younossi, Z. M.
Publication type:
Article
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 259, doi. 10.1111/apt.14423
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Jacobson, I. M.;
- Asselah, T.;
- Gane, E. J.;
- Lawitz, E.;
- Foster, G. R.;
- Roberts, S. K.;
- Thompson, A. J.;
- Willems, B. E.;
- Welzel, T. M.;
- Pearlman, B.;
- Younossi, I.;
- Racila, A.;
- Henry, L.
Publication type:
Article
Long-term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the U.S. transplant registry.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 3, p. 271, doi. 10.1111/apt.13693
By:
- Koenig, A.;
- Stepanova, M.;
- Saab, S.;
- Ahmed, A.;
- Wong, R.;
- Younossi, Z. M.
Publication type:
Article
Presence of hepatitis C (HCV) infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 10, p. 1060, doi. 10.1111/apt.13592
By:
- Sayiner, M.;
- Wymer, M.;
- Golabi, P.;
- Ford, J.;
- Srishord, I.;
- Younossi, Z. M.
Publication type:
Article
The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 3, p. 286, doi. 10.1111/apt.13269
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Nader, F.;
- Lam, B.;
- Hunt, S.
Publication type:
Article
Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 41, n. 6, p. 544, doi. 10.1111/apt.13081
By:
- Younossi, Z. M.;
- Park, H.;
- Saab, S.;
- Ahmed, A.;
- Dieterich, D.;
- Gordon, S. C.
Publication type:
Article
Editorial: can we afford the new direct-acting anti-virals for treatment of genotype 1 hepatitis C? Authors' reply.
Published in:
2014
By:
- Saab, S.;
- Younossi, Z. M.
Publication type:
Editorial
Patients' preferences and health utility assessment with SF-6D and EQ-5D in patients with chronic hepatitis C treated with sofosbuvir regimens.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 6, p. 676, doi. 10.1111/apt.12880
By:
- Stepanova, M.;
- Nader, F.;
- Cure, S.;
- Bourhis, F.;
- Hunt, S.;
- Younossi, Z. M.
Publication type:
Article
The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 6, p. 686, doi. 10.1111/apt.12881
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Saab, S.;
- Kalwaney, S.;
- Clement, S.;
- Henry, L.;
- Frost, S.;
- Hunt, S.
Publication type:
Article
Editorial: probiotics in NASH - more studies are needed.
Published in:
2014
By:
- Ong, J. P.;
- Younossi, Z. M.
Publication type:
Editorial
The impact of hepatitis C burden: an evidence-based approach.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 5, p. 518, doi. 10.1111/apt.12625
By:
- Younossi, Z. M.;
- Kanwal, F.;
- Saab, S.;
- Brown, K. A.;
- El‐Serag, H. B.;
- Kim, W. R.;
- Ahmed, A.;
- Kugelmas, M.;
- Gordon, S. C.
Publication type:
Article
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.
Published in:
Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 1, p. 3, doi. 10.1111/apt.12543
By:
- Younossi, Z. M.;
- Reyes, M. J.;
- Mishra, A.;
- Mehta, R.;
- Henry, L.
Publication type:
Article
The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 9, p. 1065, doi. 10.1111/apt.12485
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Mishra, A.;
- Venkatesan, C.;
- Henry, L.;
- Hunt, S.
Publication type:
Article
Mortality associated with alcohol-related liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 6, p. 596, doi. 10.1111/apt.12432
By:
- Trimble, G.;
- Zheng, L.;
- Mishra, A.;
- Kalwaney, S.;
- Mir, H. M.;
- Younossi, Z. M.
Publication type:
Article
Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 7, p. 703, doi. 10.1111/apt.12265
By:
- Younossi, Z. M.;
- ZhENg, L.;
- Stepanova, M.;
- VENkatesan, C.;
- Mir, H. M.
Publication type:
Article
Associations of chronic hepatitis C with metabolic and cardiac outcomes.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 6, p. 647, doi. 10.1111/apt.12234
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Nader, F.;
- Younossi, Z.;
- Elsheikh, E.
Publication type:
Article
Commentary: physical activity and NAFLD - cause or effect? Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 11/12, p. 1098, doi. 10.1111/apt.12088
By:
- Gerber, N. L.;
- Younossi, Z. M.
Publication type:
Article
Non-alcoholic fatty liver disease ( NAFLD) is associated with low level of physical activity: a population-based study.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 8, p. 772, doi. 10.1111/apt.12038
By:
- Gerber, L.;
- Otgonsuren, M.;
- Mishra, A.;
- Escheik, C.;
- Birerdinc, A.;
- Stepanova, M.;
- Younossi, Z. M.
Publication type:
Article
Caffeine is protective in patients with non-alcoholic fatty liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 1, p. 76, doi. 10.1111/j.1365-2036.2011.04916.x
By:
- Birerdinc, A.;
- Stepanova, M.;
- Pawloski, L.;
- Younossi, Z. M.
Publication type:
Article
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 8, p. 853, doi. 10.1111/j.1365-2036.2011.04808.x
By:
- Sanyal, A.;
- Younossi, Z. M.;
- Bass, N. M.;
- Mullen, K. D.;
- Poordad, F.;
- Brown, R. S.;
- Vemuru, R. P.;
- Mazen Jamal, M.;
- Huang, S.;
- Merchant, K.;
- Bortey, E.;
- Forbes, W. P.
Publication type:
Article
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 3, p. 274, doi. 10.1111/j.1365-2036.2011.04724.x
By:
- Vernon, G.;
- Baranova, A.;
- Younossi, Z. M.
Publication type:
Article
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 7, p. 801, doi. 10.1111/j.1365-2036.2011.04579.x
By:
- Baranova, A.;
- Tran, T. P.;
- Birerdinc, A.;
- Younossi, Z. M.
Publication type:
Article
Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 3, p. 487, doi. 10.1111/j.1365-2036.2010.04366.x
By:
- Estep, M.;
- Armistead, D.;
- Hossain, N.;
- Elarainy, H.;
- Goodman, Z.;
- Baranova, A.;
- Chandhoke, V.;
- Younossi, Z. M.
Publication type:
Article
Predictors of health-related quality of life in patients with chronic liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 469, doi. 10.1111/j.1365-2036.2009.04061.x
By:
- AFENDY, A.;
- KALLMAN, J. B.;
- STEPANOVA, M.;
- YOUNOSZAI, Z.;
- AQUINO, R. D.;
- BIANCHI, G.;
- MARCHESINI, G.;
- YOUNOSSI, Z. M.
Publication type:
Article
Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians.
Published in:
Alimentary Pharmacology & Therapeutics, 2009, v. 29, n. 9, p. 1019, doi. 10.1111/j.1365-2036.2009.03961.x
By:
- KALLMAN, J. B.;
- ARSALLA, A.;
- PARK, V.;
- DHUNGEL, S.;
- BHATIA, P.;
- HADDAD, D.;
- WHEELER, A.;
- YOUNOSSI, Z. M.
Publication type:
Article
Adipokines and cytokines in non-alcoholic fatty liver disease: authors’ reply.
Published in:
2008
By:
- Baranova, A.;
- Younossi, Z. M.
Publication type:
Letter
Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2008, v. 28, n. 1, p. 2, doi. 10.1111/j.1365-2036.2008.03710.x
By:
- YOUNOSSI, Z. M.
Publication type:
Article
Adipokines and cytokines in non-alcoholic fatty liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2008, v. 27, n. 5, p. 412, doi. 10.1111/j.1365-2036.2007.03586.x
By:
- JARRAR, M. H.;
- BARANOVA, A.;
- COLLANTES, R.;
- RANARD, B.;
- STEPANOVA, M.;
- BENNETT, C.;
- FANG, Y.;
- ELARINY, H.;
- GOODMAN, Z.;
- CHANDHOKE, V.;
- YOUNOSSI, Z. M.
Publication type:
Article
Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 2, p. 135, doi. 10.1111/jvh.12262
By:
- Younossi, Z. M.;
- Otgonsuren, M.;
- Henry, L.;
- Arsalla, Z.;
- Stepnaova, M.;
- Mishra, A.;
- Venkatesan, C.;
- Hunt, S.
Publication type:
Article
Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C.
Published in:
Journal of Viral Hepatitis, 2013, v. 20, n. 8, p. 550, doi. 10.1111/jvh.12080
By:
- Younossi, Z. M.;
- Stepanova, M.;
- Afendy, M.;
- Lam, B. P.;
- Mishra, A.
Publication type:
Article
Gene expression profiles associated with anaemia and ITPA genotypes in patients with chronic hepatitis C (CH-C).
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 6, p. 414, doi. 10.1111/j.1365-2893.2011.01564.x
By:
- Birerdinc, A.;
- Estep, M.;
- Afendy, A.;
- Stepanova, M.;
- Younossi, I.;
- Baranova, A.;
- Younossi, Z. M.
Publication type:
Article
Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 341, doi. 10.1111/j.1365-2893.2011.01554.x
By:
- Stepanova, M.;
- Lam, B.;
- Younossi, Y.;
- Srishord, M. K;
- Younossi, Z. M.
Publication type:
Article
Vietnamese community screening for hepatitis B virus and hepatitis C virus.
Published in:
Journal of Viral Hepatitis, 2011, v. 18, n. 1, p. 70, doi. 10.1111/j.1365-2893.2010.01278.x
By:
- Kallman, J. B.;
- Tran, S.;
- Arsalla, A.;
- Haddad, D.;
- Stepanova, M.;
- Fang, Y.;
- Wrobel, V. J.;
- Srishord, M.;
- Younossi, Z. M.
Publication type:
Article
Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C.
Published in:
Journal of Viral Hepatitis, 2010, v. 17, n. 10, p. 730, doi. 10.1111/j.1365-2893.2009.01235.x
By:
- Birerdinc, A.;
- Afendy, A.;
- Stepanova, M.;
- Younossi, I.;
- Manyam, G.;
- Baranova, A.;
- Younossi, Z. M.
Publication type:
Article
A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment.
Published in:
Journal of Viral Hepatitis, 2008, v. 15, n. 5, p. 370, doi. 10.1111/j.1365-2893.2007.00956.x
By:
- Younossi, Z. M.;
- Nader, F. H.;
- Bai, C.;
- Sjogren, R.;
- Ong, J. P.;
- Collantes, R.;
- Sjogren, M.;
- Farmer, D.;
- Ramsey, L.;
- Terra, K.;
- Gujral, H.;
- Gurung, C.;
- Srishord, M.;
- Fang, Y.
Publication type:
Article

Found: 45